Explore All 119 Venture Business Services Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | January 1, 2017 |
| Target | Ajax Health |
| Sector | Business Services |
| Investor(s) |
Aisling Capital
KKR Polaris Partners |
| Deal Type | Venture |
FILTER BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 1.8B USD |
| Size | Large |
| Type | Sector Focused |
Aisling Capital is a private investment firm focused on opportunities in the healthcare and medical technology sectors. The Firm specifically looks to invest in companies developing and commercializing innovative healthcare products, services, and technologies. Aisling Capital looks to commit $20 to $50 million per investment and prefers to be the lead investor. Aisling will consider investing in both public and private companies. Aisling Capital raised its first fund in 2000. The Firm is based in New York City.
| Deal Context for Investor | # |
|---|---|
| Overall | 38 of 56 |
| Sector: Business Services | 1 of 1 |
| Type: Venture | 24 of 29 |
| State: California | 9 of 15 |
| Country: United States | 36 of 52 |
| Year: 2017 | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-01-12 |
Syros Pharmaceuticals
Cambridge, Massachusetts, United States Syros Pharmaceuticals is a biopharmaceutical company applying a pioneering approach to discover and develop medicines that control the expression of genes with the aim of treating cancer and other serious diseases. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-02 |
BridgeBio
Palo Alto, California, United States BridgeBio is an Orphan disease drug platform with a robust portfolio of transformative drug programs that address rare diseases across oncology, cardiology, dermatology, neurology, and endocrinology. BridgeBio was founded in 2015 and is based in Palo Alto, California. |
Buy | - |
| Category | Private Equity Firm |
|---|---|
| Founded | 1976 |
| PE ASSETS | 267.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.
| Deal Context for Investor | # |
|---|---|
| Overall | 222 of 503 |
| Sector: Business Services | 7 of 19 |
| Type: Venture | 17 of 35 |
| State: California | 17 of 46 |
| Country: United States | 93 of 213 |
| Year: 2017 | 2 of 41 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-01 |
Trilogy MedWaste
Houston, Texas, United States Trilogy MedWaste is a provider of medical waste management services. Trilogy MedWaste is based in Houston, Texas. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-02 |
BridgeBio
Palo Alto, California, United States BridgeBio is an Orphan disease drug platform with a robust portfolio of transformative drug programs that address rare diseases across oncology, cardiology, dermatology, neurology, and endocrinology. BridgeBio was founded in 2015 and is based in Palo Alto, California. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 5.0B USD |
| Size | Large |
| Type | Sector Agnostic |
Polaris Partners is primarily a seed, first round, and early stage venture capital investor in information technology and life science businesses. However, Polaris also focuses on private equity investments in established companies. In this area, Polaris targets high growth middle market companies in industries including technology, healthcare, digital media, consumer products and services, and business services. The firm's investments include minority growth equity investments, recapitalizations with liquidity, and leveraged buyouts. Polaris Partners was formed in 1996 and has offices in Seattle, Washington and Waltham, Massachusetts.
| Deal Context for Investor | # |
|---|---|
| Overall | 42 of 86 |
| Sector: Business Services | 3 of 3 |
| Type: Venture | 20 of 55 |
| State: California | 7 of 13 |
| Country: United States | 39 of 77 |
| Year: 2017 | 1 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-12-10 |
Kallyope
New York City, New York, United States Kallyope is a biotechnology company focused on harnessing the potential of the gut-brain axis, Kallyope was founded in 2015 and is based in New York City, New York. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-24 |
Foodberry
Boston, Massachusetts, United States Foodberry is a food-tech innovation company that partners with food and beverage brands to develop and manufacture bite-sized snack products using plant-based coating technology. The Company’s platform draws inspiration from how nature protects fruit to create edible coatings that enable new snack formats. Foodberry was founded in 2012 and is based in Boston, Massachusetts. |
Buy | - |
